The role of indomethacin and tezosentan on renal effects induced by Bothrops moojeni Lys49 myotoxin I

Toxicon

Volumn 47, Issue 8, 2006, Pages 831-837

  Barbosa, P S F ^a   Martins, A M C ^a   Alves, R S ^a   Amora, D N ^a   Martins, R D ^a   Toyama, Marcos H ^b   Havt, A ^a   Nascimento, N R F ^c   Rocha, V L C ^a   Menezes, D B ^a   Fonteles, M C ^d   Monteiro, H S A ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c STATE UNIVERSITY OF CEARÁ   (Brazil)

^d MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

Author keywords

Bothrops moojeni; Endothelin; Myotoxin I; Renal effects

Indexed keywords

CHLORIDE; ENDOTHELIN; INDOMETACIN; LYSINE 49 MYOTOXIN 1; PHENYLEPHRINE; POTASSIUM; PROSTAGLANDIN SYNTHASE INHIBITOR; SODIUM; TEZOSENTAN; TOXIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHLORIDE TRANSPORT; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY VASCULAR RESISTANCE; MALE; MESENTERY BLOOD FLOW; NONHUMAN; PERFUSION PRESSURE; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; SNAKE; SODIUM TRANSPORT; UREA CYCLE; URINE FLOW RATE;

ANIMALS; BOTHROPS; CROTALID VENOMS; ENDOTHELINS; INDOMETHACIN; KIDNEY; MALE; PHOSPHOLIPASES A; PYRIDINES; RATS; RATS, WISTAR; SPLANCHNIC CIRCULATION; TETRAZOLES; VASODILATOR AGENTS;

BOTHROPS MOOJENI; RATTUS NORVEGICUS;

EID: 33745055225     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2006.01.012     Document Type: Article

References (36)

1. Azevedo-Marques M.M., Cupo P., Coimbra T.M., Hering S.E., Rossi M.A., and Laure C.J. Myonecrosis, myoglobinuria and acute renal failure induced by south American rattlesnake (Crotalus durissus terrificus) envenomation in Brazil. Toxicon 23 (1985) 631-636
2. Barbosa P.S.F., Havt A., Facó P.E.G., Sousa T.M., Bezerra I.S.A.M., Fonteles M.C., Toyama M.H., Marangoni S., Novello J.C., and Monteiro H.S.A. Renal toxicity of Bothrops moojeni snake venom and its main myotoxins. Toxicon 40 (2002) 1427-1435
3. Bard J.M., Luc G., Douste-Blazy P., Drouin P., Ziegler O., Jacotot B., Dachet C., De Gennes J.L., and Fruchart J.C. Effect of sinvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia. Eur. J. Clin. Pharmacol. 37 6 (1989) 545-550
4. Benigni A., and Remuzzi G. Endothelin antagonists. Lancet 353 9147 (1999) 133-138
5. Bowman R.H. Gluconeogenesis in the isolated perfused rat kidney. J. Biol. Chem. 245 (1970) 1604-1612
6. Cheng H.F., and Harris R.C. Cyclooxygenases, the kidney, and hypertension. Hypertension 43 3 (2004) 525-530
7. Chen S., Evans T., Deng D., Cukiernik M., and Chakrabarti S. Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins. Nephron 90 (2002) 86-94
8. Clozel M., Qiu C., Osterwalder R., Roeckel A., Bruneval P., Heudes D., and Clozel J.P. Effects of nonpeptide endothelin receptor antagonists in rats with reduced renal mass. J. Cardiovasc. Pharmacol. 33 4 (1999) 611-618
9. 2 from snake venom to human secreted forms. J. Mol. Evol. 31 3 (1990) 228-238
10. 2. J. Biol. Chem. 269 18 (1994) 13057-13060
11. Dennis M.J., Burrell A., Mathieson K., Willetts P., and Massey R.C. The determination of the flour improver potassium bromate in bread by gas chromatographic and ICP-MS methods. Food Addit. Contam. 11 6 (1994) 633-639
12. Fonteles M.C., Cohen J.J., Black A.J., and Wertheim S.J. Support of renal kidney function by long-chain fatty acids derived from renal tissue. Am. J. Physiol. 244 (1983) 235-246
13. Fukunaga M., Fujiwara Y., Ochi S., Yokoyama K., Shoji T., Fukuhara Y., Orita Y., Kamada T., Badr K.F., and Ueda N. Mechanism of induction of prostaglandin E2 production by endothelin 1 in cultured rat mesangial cells. Exp. Nephrol. 4 6 (1996) 340-349
14. Gordon M.C., and Samuels P. Indomethacin. Clin. Obstet. Gynecol. 38 4 (1995) 697-705
15. Harris J.B., and Cullen M.J. Muscle necrosis caused by snake venoms and toxins. Electron Microsc. Rev. 3 (1990) 183-211
16. Herman W.H., Emancipator S.N., Rhoten R.L., and Simonson M.S. Vascular and glomerular expression of endothelin-1 in normal human kidney. Am. J. Physiol. Renal Physiol. 275 (1998) 8-17
17. Jaffer F.E., Knauss T.C., Poptic E., and Abboud H.E. Endothelin stimulates PDGF secretion in cultured human mesangial cells. Kidney Int. 38 6 (1990) 1193-1198
18. Kini R.M., and Iwanaga S. Structure-function relationships of phospholipases. I: prediction of presynaptic neurotoxicity. Toxicon 24 6 (1986) 527-541
19. Kitamura A., Kagami S., Urushihara M., Kondo S., Yoshizumi M., Tamaki T., and Kuroda Y. Endothelin-1 is a potent stimulator of alpha1beta1 integrin-mediated collagen matrix remodeling by rat mesangial cells. Biochem. Biophys. Res. Commun. 299 4 (2002) 555-561
20. 2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon 42 8 (2003) 885-901
21. Martinez-Maldonado M., and Opava-Stitzer S. Free water clearance curves during saline, mannitol, glucose and urea. J. Physiol. 280 (1978) 487-497
22. Martins A.M.C., Monteiro H.S.A., Júnior E.G., Menezes D.B., and Fonteles M.C. Effects of Crotalus durissus cascavella venom in the isolated rat kidney. Toxicon 36 10 (1998) 1441-1450
23. Masaki T. The discovery of endothelins. Cardiovasc. Res. 39 3 (1998) 530-533
24. McGregor D.D. The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric blood vessels of the rat. J. Physiol. 177 (1965) 21-30
25. Mebs D., and Ownby C.L. Myotoxic components of snake venoms: their biochemical and biological activities. Pharmacol. Ther. 48 (1990) 223-236
26. Monteiro A., and Fonteles M.C. The effect of Bothrops jararaca venom on rat kidney after short-term exposure: preliminary results. Pharmacol. Toxicol. 85 4 (1999) 198-200
27. Pitts R.F. Metabolism of aminoacids by the perfused rat kidney. Am. J. Physiol. 220 (1971) 862-867
28. Simonson M.S., and Dunn M.J. Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiates beta-adrenergic-mediated cyclic adenosine monophosphate accumulation. J. Clin. Invest. 85 3 (1990) 790-797
29. Simonson M.S., and Dunn M.J. Endothelins: a family of regulatory peptides. State-of-the-art lecture. Hypertension 2 6 Pt 2 (1991) 856-863
30. 2 enzymes: classification and characterization. Biochim. Biophys. Acta 1488 (2000) 1-19 (Toxicon 36, 1441-1450)
31. Sorokin A., and Kohan D.E. Physiology and pathology of endothelin-1 in renal mesangium. Am. J. Physiol. Renal Physiol. 285 4 (2003) F579-F589
32. Takeda K., Gosiewska A., and Peterkofsky B. Similar, but not identical, modulation of expression of extracellular matrix components during in vitro and in vivo aging of human skin fibroblasts. J. Cell. Physiol. 153 3 (1992) 450-459
33. Terada Y., Yamakawa K., Sugaya A., and Toyoda N. Serum leptin levels do not rise during pregnancy in age-matched rats. Biochem. Biophys. Res. Commun. 253 3 (1998) 841-844
34. Valentin E., and Lambeau G. Increasing molecular diversity of secreted phospholipases A (2) and their receptors and binding proteins. Biochim. Biophys. Acta 1488 1-2 (2000) 59-70
35. 2 and their importance for enzymatic activity. J. Cell. Biochem. 39 4 (1989) 379-390
36. Wasler M., Davidson D.G., and Orloff J. The renal clearance of alkali-stable inulin. J. Clin. Invest. 34 (1955) 1520-1523